- Transtuzumabe2008 | First Faculty of Medicine
- Transtuzumab in adjuvant therapyPublication without faculty affiliation
- Predictive diagnosis of HER2 in gastric adenocarcinomas2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Adjuvantní a neoadjuvantní léčba časného HER pozitivního karcinomu prsu. Specifika léčby HER2 pozitivního / HR pozitivního karcinomu prsu2022 | Publication without faculty affiliation
- 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study2004 | First Faculty of Medicine